Application of Tumor Markers SCC-Ag, CEA, and TPA in Patients with Cervical Precancerous Lesions |
Farzaneh, Farah
(Preventive Gynecology Research Center, Department of Obstetrics and Gynecology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences)
Shahghassempour, Shapour (Tissue Engineering and Nanomedicine Research Center, Taleghani Teaching Hospital, Shahid Beheshti University of Medical Sciences) Noshine, Bahram (Tissue Engineering and Nanomedicine Research Center, Taleghani Teaching Hospital, Shahid Beheshti University of Medical Sciences) Arab, Maliheh (Preventive Gynecology Research Center, Department of Obstetrics and Gynecology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences) Yaseri, Mehdi (Clinical Research and Development Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences) Rafizadeh, Mitra (Department of Pathology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences) Alizadeh, Kamyab (Preventive Gynecology Research Center, Department of Obstetrics and Gynecology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences) |
1 | Tendler A, Kaufman HL, Kadish AS (2000). Increased carcinoembryonic antigen expression in cervical intraepithelial neoplasia grade 3 and in cervical squamous cell carcinoma. Hum Pathol, 31, 1357-62. DOI ScienceOn |
2 | Volgger B, Aspisirengil C, Genser-Krimbacher E, et al (2008). Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix. Cancer Lett, 262, 183-9. DOI ScienceOn |
3 | Wallace D, Hunter J, Papenfuss M, et al (2007). Pap smear screening among women >/=40 years residing at the United States-Mexico border. Health Care Women Int, 28, 799-816. DOI ScienceOn |
4 | Jesdapatarakul S, Tangjitgamol S, Nguansangiam S, Manusirivithaya S (2011). Liqui-Prep(R) versus conventional Papanicolaou smear to detect cervical cells abnormality by split-sample technique: a randomized double-blind controlled trial. Diagn Cytopathol, 39, 22-7. DOI ScienceOn |
5 | Juang CM, Wang PH, Yen MS, et al (2000). Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 76, 103-6. DOI ScienceOn |
6 | Kato H, Torigoe T (1977). Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer, 40, 1621-8. DOI |
7 | Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63. |
8 | Parkin DM, Almonte M, Bruni L, et al (2008). Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine, 11, 1-15. |
9 | Porika M, Vemunoori AK, Tippani R, et al (2010). Squamous cell carcinoma antigen and cancer antigen 125 in Southern Indian cervical cancer patients. Asian Pac J Cancer Prev, 11, 1745-7. |
10 | Reesink-Peters N, van der Velden J, Ten Hoor KA, et al (2005). Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J Clin Oncol, 23, 1455-62. DOI ScienceOn |
11 | Takeshima N, Hirai Y, Katase K, et al (1998). The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol, 68, 263-6. DOI ScienceOn |
12 | Forni F, Ferrandina G, Deodato F, et al (2007). Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. Int J Radiat Oncol Biol Phys, 69, 1145-9. DOI ScienceOn |
13 | Chen C, Yang Z, Li Z Li L (2012). Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis. Int J Gynecol Cancer, 22, 908-21. DOI ScienceOn |
14 | Cuzick J, Arbyn M, Sankaranarayanan R, et al (2008). Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine, 10, 29-41. |
15 | Esajas MD, Duk JM, de Bruijn HW, et al (2001). Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol, 19, 3960-6. DOI |
16 | Gadducci A, Cosio S, Carpi A, Nicolini A, Genazzani AR (2004). Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother, 58, 24-38. DOI ScienceOn |
17 | Jeong BK, Choi DH, Huh SJ, et al (2011). The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix. Radiat Oncol J, 29, 191-8. DOI ScienceOn |
18 | Hong JH, Tsai CS, Chang JT, et al (1998). The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys, 41, 823-30. DOI ScienceOn |
19 | Indarti J, Aziz MF, Suryawati B, Fernando D (2013). Scoring system and management algorithm assessing the role of survivin expression in predicting progressivity of HPV infections in precancerous cervical lesions. Asian Pac J Cancer Prev, 14, 1643-7. 과학기술학회마을 DOI ScienceOn |
20 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
21 | Mathew A, George PS (2009). Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide. Asian Pac J Cancer Prev, 10, 645-50. |